SCHEMBL786856

SCHEMBL786856

C[Si](C)(C)O[Si](C)(C)O[Si](C)(CCCCCC(=O)O)O[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.41
LMNA P02545 2/20 0.41
NFKB1 P19838 1/20 0.41
PMP22 Q01453 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
GPR84 Q9NQS5 8/20 0.39
PPARG P37231 7/20 0.39
PPARD Q03181 7/20 0.39
PPARA Q07869 7/20 0.39
HDAC11 Q96DB2 5/20 0.39
PTPN1 P18031 3/20 0.39
TLR2 O60603 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
FABP4 P15090 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
MEN1 O00255 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12405769 1.00 TSHR (0.41) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL12405754 0.93 TSHR (0.48) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL13038577 0.91 LMNA (0.37) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL18592636 0.86 ALDH1A1 (0.31) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL17263258 0.86 PAOX (0.38) ALDH1A1
SCHEMBL29728655 0.85 LMNA (0.42) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL13980404 0.84 PAOX (0.35) ALDH1A1
SCHEMBL19700255 0.84 TSHR (0.43) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL12405770 0.84 TSHR (0.43) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL17263259 0.83 TSHR (0.44) TSHRLMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166342-A1 Functionalized Matrices for Dispersion of Nanostructures NANOSYS, INC. (US) 2015-06-18 US disclosed
US-8916064-B2 Functionalized matrices for dispersion of nanostructures NANOSYS, INC. (US) 2014-12-23 US disclosed
US-20140151600-A1 Functionalized Matrices for Dispersion of Nanostructures NANOSYS, INC. (US) 2014-06-05 US disclosed
US-8425803-B2 Nanocrystal doped matrixes SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-04-23 US disclosed
US-20130043433-A1 Functionalized Matrixes for Dispersion of Nanostructures NANOSYS, INC. (US) 2013-02-21 US disclosed
US-20120068118-A1 NANOCRYSTAL DOPED MATRIXES SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068118-A1 NANOCRYSTAL DOPED MATRIXES STRA6, EPHA6, PIR TSHR 4278/4885LMNA 1318/4885NFKB1 4497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.